N-Acetylcysteine, an ROS Inhibitor, Alleviates the Pathophysiology of Hyperthyroidism-Induced Cardiomyopathy via the ROS/Ca²⁺ Pathway

Hyperthyroidism is common and can induce cardiomyopathy, but there is no effective therapeutic strategy. The purpose of this study was to investigate the molecular mechanism of hyperthyroidism-induced cardiomyopathy (HTC) and the effect of N-acetylcysteine (NAC), an ROS inhibitor, on the pathophysio...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mengni Bao, Xiumeng Hua, Han Mo, Zhe Sun, Bo Xu, Xiao Chen, Mengda Xu, Xinjie Xu, Jiangping Song
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-08-01
coleção:	Biomolecules
Assuntos:	hyperthyroidism-induced cardiomyopathy NAC ROS/Ca<sup>2+</sup> fibrosis apoptosis hypertrophy
Acesso em linha:	https://www.mdpi.com/2218-273X/12/9/1195
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!